1 / 26

Lawrence N Shulman, MD Dana-Farber Cancer Institute Brigham and Women’s Hospital

Computerized Chemotherapy Order Entry (COE) Lessons Learned from Development, Implementation and Maintenance. Lawrence N Shulman, MD Dana-Farber Cancer Institute Brigham and Women’s Hospital. Critical Components for Developing COE. High level support Administrative leadership

jeb
Download Presentation

Lawrence N Shulman, MD Dana-Farber Cancer Institute Brigham and Women’s Hospital

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Computerized Chemotherapy Order Entry (COE)Lessons Learned from Development, Implementation and Maintenance Lawrence N Shulman, MD Dana-Farber Cancer Institute Brigham and Women’s Hospital

  2. Critical Components for Developing COE High level support • Administrative leadership • Clinical leadership • Financial support • Programmatic support • Atmosphere of “this will happen” – life is not a democracy • Fair and Just Culture

  3. Basic Principles for Chemotherapy Ordering and Administration Shared responsibility • Physicians, nurses, and pharmacists all assume “complete” responsibility • No group abdicates responsibility for any component of care • Atmosphere where communication, questioning, and discussion are supported • Ultimately, senior clinicians, administrators and trustees accept responsibility for actions of staff

  4. COE Implementation and Continued Development – The Team Multidisciplinary team • Co-leaders – MD/IS analyst/IS programmer • MDs – clinicians, representatives from P&T, and fellows • Nursing • Pharmacy leadership and staff • IS staff – analysts, programmers and “builders” • Protocol office Frequent meetings – 2x/month x 10 yrs, now once/month Equal voice for all at table

  5. COE- Principles of Implementation and Continued Development • Compartmentalized risk analysis and approach • Automation of any component of work possible • Iterative process

  6. Process #1 Error Rate 1/10 Process #2 Error Rate 1/10 Process #3 Error Rate 1/10 Overall Error Rate 3/10 (30%)

  7. 3 People involved Error Rate 1/10 for each Overall Error Rate 1/1000 Process #1 Process #2 Process automated Error rate 0 3 People involved Error Rate 1/10 for each Overall Error Rate 1/1000 Process #3 Overall Error Rate 2/1000 (0.2%)

  8. COE – Iterative Process of Development and Deployment • Don’t attempt to develop ‘ideal’ system before deployment • What are the minimal requirements to implement the next system/step? • Look for incremental improvements in safety • Priority lists – and continuous re-evaluation, related to Interventions program and “error events” • Continuous development – for ever!!

  9. COE- Principles of Implementation and Continued Development Safety over convenience • Conscious decision issue by issue Reduction in ambiguity • Hydration and criteria to initiate treatment Standardization Conscious evaluation of work flow effects • Looking for trade-offs – what can a system do to aid clinicians as well as enhance safety?

  10. COE- Principles of Implementation and Continued Development Standardization!! Templated Treatment Regimens • Consensus on accepted regimens for each disease group • Consensus on specifics of each regimen (one CMF) • Recommended antiemetics included • All necessary ancillary meds included • Recommended hydration orders included

  11. COE- Principles of Implementation and Continued Development Patients linked to approved investigational protocol registration • Pts registered through protocol office who reviews consent and eligibility criteria • Protocol office assigns pt to protocol and specifics of treatment auto-templated into orders including assignment to specific treatment “arm”

  12. Patient Safety – IT Infrastructure Availability of All Necessary Patient Data • Integrated systems • Clinician documentation – MD/RN/etc – electronic medical record • Lab, radiology, pathology data • On-line ordering treatment regimens • On-line protocols and consents – NO paper copies as primary source • On-line consent verification • Universal protocol-enrollment notification in electronic record, chemotherapy order entry system, etc

  13. Jane Doe

  14. Jane Doe Jane Doe

  15. Jane Doe Jane Doe

  16. Jane Doe

  17. Jane Doe

  18. Jane Doe

  19. Jane Doe

  20. Jane Doe

  21. COEContinuous Quality Improvement Fair and Just Culture (non-punitive) • Support for error identification • Definition of errors – concentrating on potential errors – “near misses” – those that are caught and do not reach the pt • Concentration on systems – not individuals • Root Cause Analysis system for serious errors • Need to sort out truly problematic individuals

  22. COE – Response to Major Errors The RCA Process • SWAT team – meets on short notice • Convener and Facilitator • High level clinical and administrative participation • Multidisciplinary • Ideally, those who need to be present to make decisions are involved • Focuses on systems, not individuals • Reports to MSEC • Reports to Board level QI/Risk Management Committee

  23. COE – Continuous Cycle Improvement The Interventions Program • Facile reporting mechanism for staff • Nursing, pharmacy, etc • Non-punitive – staff have told us this will stop if they fear punitive action for their colleagues • Tabulation and analysis of data to look for trends – by P&T committee and results, without clinician identification, given to COE team • Rounding system – “What has occurred today that worries you about pt safety?” • Reports to MSEC • Reports to Board level QI/Risk Management Committee

  24. Patient SafetyPatient Involvement makes it better • Patients involved at all levels, including in meetings with leadership and trustees • Identification of risk issues (they see things we sometimes miss – and often have business background with experience in systems) • Identification of potential solutions • Medication error project • High level committees including trustee level QI Risk Management committee • By-in of patients when changes are made • Patients not involved in RCA (peer review issues)

  25. Patient Safety Full disclosure of errors to patients and families • Institute policy • Must be timely • Must be complete • Institute support for those involved • Positive outcomes

  26. Computerized Chemotherapy Order Entry System as a Model • All in all - a success • Involvement of all needed parties • Culture of safety, risk-mitigation, and cooperation of all groups • Culture of continuous improvement – there is always something that can be done better • It has been both fun and rewarding

More Related